Across TCGA pan-cancer cohorts, OR11L1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR11L1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OR11L1 RNA is repressed in tumor relative to normal tissue. In most cancer types OR11L1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA are the cancer types where OR11L1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR11L1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−0.178	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: OR11L1 RNA expression & survival · all OR11L1 data types